MedPath
NMPA Approval

Ibuprofen Suspension

国药准字H20103544

April 8, 2020

Drug Information

布洛芬混悬液

一洋

口服混悬剂

2%

化学药品

April 8, 2020

Company Information

Applicant Company

江苏省高邮市长兴路8号

Manufacturing Company

江苏省高邮市长兴路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

布洛芬混悬液 - NMPA 批准文号 | MedPath